Citadel Advisors
DRIO icon

Citadel Advisors’s DarioHealth DRIO Stock Holding History

Citadel Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
24,289
+3,829
+19% +$28.5K ﹤0.01% 12288
2026
Q1 		$164K Buy
+20,460
New +$214K ﹤0.01% 11607
2025
Q1 		– Sell
-3,597
Closed -$50.8K – 14677
2024
Q4 		$56.5K Buy
3,597
+279
+8% +$4.83K ﹤0.01% 12254
2024
Q3 		$74.3K Buy
3,318
+480
+17% +$9.73K ﹤0.01% 11486
2024
Q2 		$67.5K Buy
+2,838
New +$80.4K ﹤0.01% 11415
2024
Q1 		– Sell
-1,971
Closed -$74.7K – 14711
2023
Q4 		$67.8K Buy
1,971
+719
+57% +$25.6K ﹤0.01% 11422
2023
Q3 		$82.1K Sell
1,252
-1,908
-60% -$129K ﹤0.01% 11143
2023
Q2 		$253K Sell
3,160
-1,531
-33% -$116K ﹤0.01% 9382
2023
Q1 		$387K Buy
4,691
+4,604
+5,292% +$452K ﹤0.01% 8841
2022
Q4 		$7.45K Sell
87
-1,058
-92% -$95.2K ﹤0.01% 13824
2022
Q3 		$106K Sell
1,145
-6,135
-84% -$659K ﹤0.01% 11036
2022
Q2 		$895K Buy
7,280
+3,349
+85% +$393K ﹤0.01% 7278
2022
Q1 		$459K Buy
3,931
+2,765
+237% +$457K ﹤0.01% 9594
2021
Q4 		$303K Sell
1,166
-424
-27% -$129K ﹤0.01% 10896
2021
Q3 		$434K Buy
1,590
+997
+168% +$288K ﹤0.01% 10227
2021
Q2 		$253K Sell
593
-247
-29% -$94K ﹤0.01% 11668
2021
Q1 		$324K Buy
+840
New +$378K ﹤0.01% 10668
2019
Q4 		– Sell
-132
Closed -$16K – 9229
2019
Q3 		$16K Buy
132
+100
+313% +$17.3K ﹤0.01% 8984
2019
Q2 		$6K Sell
32
-74
-70% -$19.2K ﹤0.01% 9067
2019
Q1 		$31K Buy
+106
New +$31.5K ﹤0.01% 8983
2018
Q4 		– Sell
-45
Closed -$17K – 9233
2018
Q3 		$17K Sell
45
-2
-4% -$918 ﹤0.01% 9037
2018
Q2 		$24K Buy
+47
New +$30.7K ﹤0.01% 8604

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citadel Advisors's DRIO Position: Q2 2026 in Review

Citadel Advisors increased its DarioHealth (DRIO) stake by 19% in Q2 2026, buying an estimated $28.5K and bringing the position to 24,289 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #12288.

Citadel Advisors first reported a position in DRIO in Q2 2018 and has held it in 22 quarters since. The position peaked at $895K in Q2 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

  • Citadel Advisors held 24,289 shares of DarioHealth worth $160K as of Q2 2026.
  • Citadel Advisors bought 3,829 DarioHealth shares in Q2 2026, an estimated $28.5K.
  • DarioHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12288 holding.
  • Citadel Advisors first reported a position in DarioHealth in Q2 2018 and has held it in 22 quarters since.
  • Citadel Advisors's DarioHealth position peaked at $895K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.